Paula Newton speaks with co-founder and Chair of Moderna, Noubar Afeyan, about his hopes for the release of Ruben Vardanyan, ...

It's been nearly five years since Moderna (NASDAQ: MRNA) emerged as a biotech industry disruptor, with its COVID-19 vaccine ...

Moderna stock skidded on reports Robert F. Kennedy Jr. is considering pulling funding for its bird flu vaccine. Is MRNA stock a sell?

Biotech is an area that may offer your portfolio growth today and earnings stability tomorrow. The idea is a biotech stock ...

Citigroup assumed coverage on shares of Moderna (NASDAQ:MRNA – Free Report) in a research report report published on Thursday ...

Some food trends are just fun. That's the category where AP food writer Katie Workman puts this one: Pearl-shaped foods that ...

One of the most underappreciated applications of artificial intelligence in the corporate world involves its role in writing ...

There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.

U.S. health agency leadership and policymakers seem intent on undermining trust in mRNA, the technology that saved millions of lives during the covid pandemic and has shown promise in addressing a ...

Tyson Foods CEO Donnie King has seen his annual executive rewards leap from $13 million in 2023 to $22.7 million in 2024. To ...

The pharmaceutical company said, “The allegations that came out in the media are entirely baseless, distorted, and part of a smear campaign" ...

The Trump administration has not staffed an office established by Congress to prepare the nation for future pandemics, ...